Biopharmaceuticals
Neurology
News Release - January 29, 2020
vasopharm Completes Patient Enrollment for Phase III Traumatic Brain Injury Trial (NOSTRA)
Source: vasopharm
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.